Literature DB >> 2671865

Modulation of ras expression by anti-sense, nonionic deoxyoligonucleotide analogs.

D Brown1, Z P Yu, P Miller, K Blake, C Wei, H F Kung, R J Black, P O Ts'o, E H Chang.   

Abstract

Anti-ras oligodeoxyribonucleoside methylphosphonates (ONMP's) complementary to the initiation codon region have been synthesized to explore their efficacy and specificity on ras-p21 translation. ONMP (IC-0) precisely complementing the first initial 11 nucleotides of the Balb-ras initiation codon region acts in a dose-dependent manner to inhibit p21 translation by a rabbit reticulocyte lysate. At 100 microM, IC-0 inhibits the cell-free translation of p21 close to completion. The two control oligomers containing one or two nucleotide mismatches were significantly less effective than IC-0 at the equivalent concentration. In living cells, a perfectly matched ONMP directed against the initiation codon region inhibited Ha-ras p21 expression by 90% at a concentration of 50 microM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671865

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  8 in total

Review 1.  Oligonucleotide treatment of ras-induced tumors in nude mice.

Authors:  E Wickstrom
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

2.  Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.

Authors:  D A Stewart; S D Thomas; C A Mayfield; D M Miller
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

3.  Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers.

Authors:  L Kibler-Herzog; G Zon; B Uznanski; G Whittier; W D Wilson
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

4.  Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.

Authors:  A Storey; D Oates; L Banks; L Crawford; T Crook
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

5.  Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes).

Authors:  S Akhtar; S Basu; E Wickstrom; R L Juliano
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

Review 6.  Antisense technology for cancer therapy: does it make sense?

Authors:  G Carter; N R Lemoine
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

Review 7.  Antisense oligonucleotide therapy for urologic tumors.

Authors:  Ingo Kausch; Andreas Böhle
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

8.  Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.

Authors:  T Skorski; P Kanakaraj; D H Ku; M Nieborowska-Skorska; E Canaani; G Zon; B Perussia; B Calabretta
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.